ADAM10 and acute lymphoblastic leukemia: ADAM10, a key sheddase of numerous transmembrane proteins, including receptors and ligands critical for cell signaling, may contribute to the shedding of therapeutic targets on ALL cells following chemotherapy (14, 15).This shedding could represent a novel mechanism of drug resistance or altered drug sensitivity in these patients.